Government official: Coronavirus vaccine Trial starts Monday, March 16th.. – Chính-phủ Hoa-kỳ bắt đầu Thử-nghiệm lâm sàng vaccine kháng virus Corona Thứ Hai, 16 Tháng 03!

Government official: Vaccine trial starts Monday.

Image result for Government official: Coronavirus vaccine trial starts Monday

A clinical trial evaluating a vaccine designed to protect against the new coronavirus will begin Monday.

Tin nóng: Đợt Vaccine COVID-19 thử nghiệm lâm sàng đầu tiên giao vào Thứ Hai, 16 Tháng Ba.

Mỹ bắt đầu thử nghiệm lâm sàng vaccine kháng virus corona
(Mời đọc phần Việt-ngữ bên dưới – Cám ơn)

Government official: Coronavirus vaccine trial starts Monday
A clinical trial evaluating a vaccine designed to protect against the new coronavirus will begin Monday.

By ZEKE MILLER Associated Press
15 March 2020, 21:16

WASHINGTON — The first participant in a clinical trial for a vaccine to protect against the new coronavirus will receive an experimental dose on Monday, according to a government official.
The National Institutes of Health is funding the trial, which is taking place at the Kaiser Permanente Washington Health Research Institute in Seattle. The official who disclosed plans for the first participant spoke on condition of anonymity because the move has not been publicly announced.
Public health officials say it will take a year to 18 months to fully validate any potential vaccine.

A researcher at Protein Sciences moves a vial in a lab, Thursday, March 12, 2020, in Meriden, Conn. The biotech company is currently researching a vaccine for COVID-19. For most people, the new coronavirus causes only mild or moderate symptoms, such as fever and cough. For some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia. The vast majority of people recover from the new virus. (AP Photo/Jessica Hill)


Testing will begin with 45 young, healthy volunteers with different doses of shots co-developed by NIH and Moderna Inc. There’s no chance participants could get infected from the shots, because they don’t contain the virus itself. The goal is purely to check that the vaccines show no worrisome side effects, setting the stage for larger tests.
Dozens of research groups around the world are racing to create a vaccine as COVID-19 cases continue to grow. Importantly, they’re pursuing different types of vaccines — shots developed from new technologies that not only are faster to produce than traditional inoculations but might prove more potent. Some researchers even aim for temporary vaccines, such as shots that might guard people’s health a month or two at a time while longer-lasting protection is developed.

AP: Government official: Coronavirus vaccine trial starts Monday


Also in the works: Inovio Pharmaceuticals aims to begin safety tests of its vaccine candidate next month in a few dozen volunteers at the University of Pennsylvania and a testing center in Kansas City, Missouri, followed by a similar study in China and South Korea.
Even if initial safety tests go well, “you’re talking about a year to a year and a half” before any vaccine could be ready for widespread use, according to Dr. Anthony Fauci, director of NIH’s National Institute of Allergy and Infectious Diseases.
That still would be a record-setting pace. But manufacturers know the wait — required because it takes additional studies of thousands of people to tell if a vaccine truly protects and does no harm — is hard for a frightened public.

Image result for Official says coronavirus vaccine trial starting Monday
President Trump speaks at COVID-19 briefing
The White House task force gives an update on the coronavirus epidemic.

President Donald Trump has been pushing for swift action on a vaccine, saying in recent days that the work is “moving along very quickly” and he hopes to see a vaccine “relatively soon.”
Today, there are no proven treatments. In China, scientists have been testing a combination of HIV drugs against the new coronavirus, as well as an experimental drug named remdesivir that was in development to fight Ebola. In the U.S., the University of Nebraska Medical Center also began testing remdesivir in some Americans who were found to have COVID-19 after being evacuated from a cruise ship in Japan.
For most people, the new coronavirus causes only mild or moderate symptoms, such as fever and cough. For some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia. The worldwide outbreak has sickened more than 156,000 people and left more than 5,800 dead. The death toll in the United States is more than 50, while infections neared 3,000 across 49 states and the District of Columbia.
The vast majority of people recover. According to the World Health Organization, people with mild illness recover in about two weeks, while those with more severe illness may take three weeks to six weeks to recover….

Image result for Government official: Coronavirus vaccine trial starts Monday

Mỹ bắt đầu thử nghiệm lâm sàng vaccine kháng virus corona

16/03/2020 | Zing.vn
Quan chức chính phủ Mỹ cho biết quá trình thử nghiệm đánh giá lâm sàng vaccine kháng virus corona sẽ bắt đầu từ ngày 16/3.
Nhóm tình nguyện viên đầu tiên sẽ nhận vaccine trong ngày 16/3.
Cơ quan cấp quỹ cho cuộc thử nghiệm là Viện Y tế Quốc gia. (The National Institutes of Health )

Buổi tiêm thử nghiệm sẽ diễn ra tại Viện Y tế Kaiser Permanente ở Seattle, bang Washington, AP dẫn nguồn tin giấu tên trong chính phủ Mỹ.
Đợt thử nghiệm lâm sàng đầu tiên cho vaccine có 45 tình nguyện viên tham gia. Tất cả đều là người trẻ và có tình trạng sức khỏe tốt.

Các tình nguyện viên sẽ nhận những liều lượng vaccine khác nhau, do Viện Y tế Quốc gia và công ty Moderna phối hợp phát triển.

Vị quan chức cho biết tình nguyện viên không chịu rủi ro nhiễm bệnh từ vaccine vì trong thành phần điều chế không có virus. Mục tiêu thử nghiệm nhằm xác định vaccine không gây ra tác dụng phụ đáng lo ngại, mở đường cho bước thử nghiệm quy mô lớn.
Giới chức y tế Mỹ trước đó cho biết mọi vaccine có tiềm năng kháng được chủng virus corona mới (SARS-CoV-2) đều phải mất từ 12-18 tháng để phát triển.

Hàng chục tổ chức nghiên cứu trên khắp thế giới đang chạy đua phát triển vaccine cho Covid-19, căn bệnh do virus SARS-CoV-2 gây nên.
Một số nhà nghiên cứu còn hướng đến phát triển vaccine tạm thời trong thời gian chờ đợi vaccine hoàn thiện được phát triển. Biện pháp này giúp người tiêm phòng có thể miễn dịch với virus trong khoảng 1-2 tháng sau mỗi lần tiêm….

A researcher at Protein Sciences works in a lab

To Read More:
US government official: Coronavirus vaccine trial starts Monday
National Institutes of Health reportedly is funding the trial